Academic literature on the topic 'Primary hyperoxaluria type 1'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Primary hyperoxaluria type 1.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Primary hyperoxaluria type 1"
Cochat, Pierre. "Primary hyperoxaluria type 1." Kidney International 55, no. 6 (June 1999): 2533–47. http://dx.doi.org/10.1046/j.1523-1755.1999.00477.x.
Full textAjzensztejn, M. J., N. J. Sebire, R. S. Trompeter, and S. D. Marks. "Primary hyperoxaluria type 1." Archives of Disease in Childhood 92, no. 3 (March 1, 2007): 197. http://dx.doi.org/10.1136/adc.2006.107334.
Full textAbukhatwah, Mohamed W., Samia H. Almalki, Mohammed S. Althobaiti, Abdulla O. Alharbi, Najla K. Almalki, and Naglaa M. Kamal. "Primary hyperoxaluria Type 1." Medicine 99, no. 25 (June 19, 2020): e20371. http://dx.doi.org/10.1097/md.0000000000020371.
Full textKumar, Aman, Prateek Kinra, and A. W. Kashif. "Autopsy Findings in an Infant with Primary Hyperoxaluria (Type-1)." Annals of Pathology and Laboratory Medicine 7, no. 12 (December 30, 2020): C178–182. http://dx.doi.org/10.21276/apalm.2908.
Full textCochat, P., A. Deloraine, M. Rotily, F. Olive, I. Liponski, and N. Deries. "Epidemiology of primary hyperoxaluria type 1." Nephrology Dialysis Transplantation 10, supp8 (January 1, 1995): 3–7. http://dx.doi.org/10.1093/ndt/10.supp8.3.
Full textIchiyama, Arata, Toshiaki Oda, and Eiko Maeda-Nakai. "Primary Hyperoxaluria Type 1 in Japan." Cell Biochemistry and Biophysics 32, no. 1-3 (2000): 171–76. http://dx.doi.org/10.1385/cbb:32:1-3:171.
Full textTakayama, Tatsuya, Masao Nagata, Arata Ichiyama, and Seiichiro Ozono. "Primary Hyperoxaluria Type 1 in Japan." American Journal of Nephrology 25, no. 3 (2005): 297–302. http://dx.doi.org/10.1159/000086361.
Full textCochat, Pierre, Aurélia Liutkus, Sonia Fargue, Odile Basmaison, Bruno Ranchin, and Marie-Odile Rolland. "Primary hyperoxaluria type 1: still challenging!" Pediatric Nephrology 21, no. 8 (August 2006): 1075–81. http://dx.doi.org/10.1007/s00467-006-0124-4.
Full textFrishberg, Yaacov, Sofia Feinstein, Choni Rinat, and Alfred Drukker. "Hypothyroidism in primary hyperoxaluria type 1." Journal of Pediatrics 136, no. 2 (February 2000): 255–57. http://dx.doi.org/10.1016/s0022-3476(00)70112-0.
Full textFrishberg, Yaacov, Georges Deschênes, Jaap W. Groothoff, Sally-Anne Hulton, Daniella Magen, Jérôme Harambat, William G. van’t Hoff, et al. "Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1." Clinical Journal of the American Society of Nephrology 16, no. 7 (May 13, 2021): 1025–36. http://dx.doi.org/10.2215/cjn.14730920.
Full textDissertations / Theses on the topic "Primary hyperoxaluria type 1"
Von, Schnakenburg Claus Christian. "Molecular analysis of the AGXT gene and linkage studies in primary hyperoxaluria type 1." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.299831.
Full textDEMARTA, JOCELYNE. "L'hyperoxalurie primaire de type i de revelation tardive chez l'adulte : a propos de deux cas." Reims, 1992. http://www.theses.fr/1992REIMM081.
Full textNewbound, Garret C. "Transcriptional control of human t-cell leukemia virus type-1 in primary lymphocytes /." The Ohio State University, 1997. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487948440826361.
Full textHayman, Anna. "The biodiversity of human immunodeficiency virus type 1 : evolution during primary infection and transmission." Thesis, University College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.252357.
Full textEstève, Julie. "Transfert de gènes dans les cellules souches pluripotentes induites : application à la thérapie génique de l'hyperoxalurie primitive de type 1." Thesis, Bordeaux, 2018. http://www.theses.fr/2018BORD0280/document.
Full textPrimary hyperoxaluria type 1 (or PH1) is an inherited metabolic disorder related to the deficiency of the hepatic AGT enzyme (alanine:glyoxylate aminotransferase), which is encoded by the AGXT gene. In PH1 patients, this deficiency leads to oxalate overexcretion by liver, followed by urine filtration and complexation with calcium to form massive calcium-oxalate nephrolithiasis potentially leading to chronic renal failure. The only available curative treatment is combined hepatorenal allogeneic engraftment, which is currently limited by the availability of transplant donors, significant morbidity and mortality, and the need for long-term immunosuppressive treatment. The aim of our research project is to develop gene therapy for PH1, consisting in engraftment of genetically corrected autologous liver cells. Considering that adult hepatocytes are hardly available and expandable in vitro, we chose to explore the use of induced pluripotent stem cells (iPSCs) to produce human liver cells for application in regenerative medicine. We derived and characterized iPSC lines from PH1 patient fibroblasts after transient expression of reprogramming factors delivered by Sendai virus vectors. We developed two additive gene therapy strategies by inserting a minigene encoding an optimized AGXT cDNA sequence using (1) a lentiviral vector designed for liver-specific expression and (2) homologous recombination process at the AAVS1 locus favoured by the targeted DNA cutting system “CRISPR/Cas9”. Finally, we highlighted therapeutic cassette expression after hepatic differentiation of genetically corrected iPSCs. These results pave the way for regenerative medicine for PH1 by transplantation of genetically modified autologous hepatocyte-like cells derived from patient-specific iPSCs
Hildick, Keri. "Mechanisms underlying the trafficking and distribution of cannabinoid receptor type 1 in primary hippocampal neurons." Thesis, University of Bristol, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654590.
Full textRaker, Verena [Verfasser]. "Herpes simplex virus type 1 (HSV-1) infection alters growth factor signaling in primary cortical brain cells / Verena Raker." Hannover : Bibliothek der Tierärztlichen Hochschule Hannover, 2017. http://d-nb.info/1150340320/34.
Full textLoro, Emanuele Loro. "Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells." Doctoral thesis, Università degli studi di Padova, 2010. http://hdl.handle.net/11577/3423200.
Full textLa distrofia miotonica di tipo 1 (DM1) è causata dall'espansione (CTG)n nella regione trascritta ma non tradotta al 3' del gene DMPK. I trascritti mutati sono trattenuti in foci nucleari, i quali sequestrano diverse proteine leganti RNA spesso alterandone le funzioni (i.e. regolazione dello splicing). A livello del muscolo, i meccanismi patogenetici che portano a miotonia, debolezza e perdita di massa dei muscoli distali, non sono ad oggi chiari. Otto linee di mioblasti primari umani, ottenuti da biopsie di pazienti affetti da DM1 nelle forme adulta e congenita (range di espansione tra 90 e 1800 CTG), sono state differenziate ed innervate con successo, ottenendo miotubi in grado i contrarre. L'analisi morfologica e la quantificazione di diversi marker di miogenesi mediante RT-PCR e Western blotting, hanno indicato che il diferenziamento in vitro dei mioblasti primari DM1 è indistinguibile da quello ottenuto con mioblasti di controllo. In ciascuna linea DM1 è stata confermata l'espansione (CTG)n mediante long-PCR ed ibridizzazione in situ. Inoltre, nei miotubi DM1 è stato rilevata l'alterazione dello splicing del recettore per l'insulina e di MBNL1, caratteristica del fenotipo DM1. A 15 giorni di differenziamento, una considerevole perdita di miotubi DM1 ha suggerito l'attivazione di pathways catabolici, come confermato dalla presenza di marker di apoptosi (taglio proteolitico della caspasi 3, rilascio di citocromo c dai mitocondri, frammentazione della cromatina) e di autofagia (aumento dei livelli di LC3 lipidato e di P62). Il trattamento con l'inibitore delle caspasi Z-VAD si è dimostrato efficace nell'attenuare la riduzione del numero di mionuclei e del calibro medio dei miotubi a 15 giorni di differenziamento. Proponiamo quindi che la compromissione muscolare tipica della DM1 sia dovuta, più che ad un'alterata miogenesi, a problemi nei meccanismi di mantenimento/rigenerazione, che si esplicano attraverso la prematura attivazione di apoptosi e/o autofagia
Villablanca, Andrea. "Genetic background of familial primary hyperparathyroidism /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-520-4/.
Full textGaston, Andrea Michelle Marshall. "Adolescents with type 1 diabetes mellitus : an exploration of patients' and their primary caregivers' illness representations." Thesis, University of Leeds, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.410941.
Full textBooks on the topic "Primary hyperoxaluria type 1"
Franco, Brunella. Oral-facial-digital type 1 syndrome. Edited by Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0319_update_001.
Full textMeiners, Antonia, Uwe Otto, Herman Melville, Wolfgang Condrus, Helmut Krauss, and Herbert Stass. Moby Dick, 1 Cassette. Patmos, 2002.
Find full textMelville, Herman. Moby Dick: Part 1. Adamant Media Corporation, 2001.
Find full textDickens, Charles. Oliver Twist: Vol. 1. Independently published, 2020.
Find full textOliver Twist (centenary Cover 1). Penguin Random House, 2012.
Find full textMelville, Herman. Moby Dick Readalong (Illustrated Classics Collection 1). American Guidance Service, 1994.
Find full textMoriuchi, Hiroyuki. Human T-cell Lymphotropic Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0010.
Full textLevy, David. Macrovascular complications, hypertension, and lipids. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198766452.003.0008.
Full textHarrison, Mark. Errors. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198765875.003.0066.
Full textBulterys, Marc, Julia Brotherton, and Ding-Shinn Chen. Prevention of Infection-Related Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0066.
Full textBook chapters on the topic "Primary hyperoxaluria type 1"
Danpure, C. J., P. J. Cooper, P. R. Jennings, P. J. Wise, R. J. Penketh, and C. H. Rodeck. "Enzymatic Prenatal Diagnosis of Primary Hyperoxaluria Type 1: Potential and Limitations." In Studies in Inherited Metabolic Disease, 286–88. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1069-0_29.
Full textDanpure, C. J., and P. R. Jennings. "Deficiency of Peroxisomal Alanine: Glyoxylate Aminotransferase in Primary Hyperoxaluria Type 1." In Proceedings in Life Sciences, 374–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71325-5_40.
Full textDanpure, C. J., and P. R. Jennings. "Enzymatic Heterogeneity in Primary Hyperoxaluria Type 1 (Hepatic Peroxisomal Alanine: Glyoxylate Aminotransferase Deficiency)." In Studies in Inherited Metabolic Disease, 205–7. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1259-5_32.
Full textRaghavan, K. G., and K. V. Inamdar. "Role of Hydroxypyruvate in the Manifestation of Primary Hyperoxaluria L-Glyceric Aciduria Type-II." In Urolithiasis 2, 9–12. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2556-1_2.
Full textMarangella, M., M. Petrarulo, C. Vitale, D. Cosseddu, and F. Linari. "Glycolate and Oxalate Plasma Levels and Renal Handling in Patients With Type 1 Primary Hyperoxaluria." In Urolithiasis 2, 79. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2556-1_16.
Full textIshikawa, K., T. Suzuki, T. Funai, K. Nishiyama, C. Uchida, and A. Ichiyama. "A liver enzyme, serine:pyruvate/alanine:glyoxylate aminotransferase and its mutant in a primary hyperoxaluria type 1 case." In Biochemistry of Vitamin B6 and PQQ, 337–41. Basel: Birkhäuser Basel, 1994. http://dx.doi.org/10.1007/978-3-0348-7393-2_53.
Full textSuzuki, Toshiaki, Kozo Nishiyama, Tsuneyoshi Funai, Keiji Tanaka, Akira Ichihara, and Arata Ichiyama. "Energy-Dependent Degration of a Mutant Serine:Pyruvate/Alanin: Glyoxylate Aminotransferase in a Primary Hyperoxaluria Type 1 C." In Intracellular Protein Catabolism, 137–40. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0335-0_16.
Full textThompson, G. N., P. Purkiss, and C. J. Danpure. "The Subcellular Metabolism of Glyoxylate in Primary Hyperoxaluria Type 1: The Relationship Between Glycine Production and Oxalate Overproduction." In Studies in Inherited Metabolic Disease, 212–14. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1259-5_34.
Full textPetrarulo, M., M. Marangella, D. Cosseddu, and F. Linari. "Primary Hyperoxaluria Type 2: Specific and Simple High-Performance Liquid Chromatographic Determination for L-Glyceric Acid in Body Fluids." In Urolithiasis 2, 145. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2556-1_49.
Full textWatts, R. W. E., and M. A. Mansell. "Primary Hyperoxaluria." In Oxalate Metabolism in Relation to Urinary Stone, 65–81. London: Springer London, 1988. http://dx.doi.org/10.1007/978-1-4471-1626-4_5.
Full textConference papers on the topic "Primary hyperoxaluria type 1"
Mbeledogu, Chukwudumebi, Sally-Anne Hulton, Ashish Chikermane, Girish Gupte, Khalid Sharif, Evelyn Ong, Lauren Johansen, Indra Van Mourik, Chayarani Kelgeri, and Jane Hartley. "L6 Morbidity associated with primary hyperoxaluria type 1 (PH1) following liver transplantation: an aid for counselling of families." In Abstracts of the BSPGHAN Annual Meeting, 25–27 April 2022. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/flgastro-2022-bspghan.69.
Full textYang, Xiaozhou, Yanyun Yang, Qin Cai, Ying Zhao, Ao Fang, Weiwei Hu, and Anshi Xu. "Primary experiments on 2-D and 1-D fiber-type optical phased array." In Asia Pacific Optical Communications, edited by Ken-ichi Kitayama, Pierpaolo C. Ghiggino, Kim Roberts, and Yikai Su. SPIE, 2008. http://dx.doi.org/10.1117/12.803108.
Full textLeicht, Douglas, and Kirk Olsen. "Comparison of 15-5PH Stainless Steel Type 1 versus Type 2 Fatigue Data for Aircraft Primary Structural Elements." In SAE 2015 AeroTech Congress & Exhibition. 400 Commonwealth Drive, Warrendale, PA, United States: SAE International, 2015. http://dx.doi.org/10.4271/2015-01-2613.
Full textKosmider, Beata, Liudmila Vlasenko, Nathaniel Marchetti, Sudhir Bolla, Chenna Mandapati, Nathaniel Xander, Gerard Criner, and Karim Bahmed. "Abstract 500: Impairment of DNA double strand break repair in human primary alveolar type II cells in emphysema." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-500.
Full textHuang, Jianguo, Mark Chen, Melodi J. Whitley, Hsuan-Cheng Kuo, Andrea Walens, Yvonne M. Mowery, David V. Mater, et al. "Abstract 2810: Using CRISPR/Cas9 to generate primary soft tissue sarcoma in genetically engineered and wild-type mice." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2810.
Full textSharma, Anil K., and Rolf D. Hubmayr. "Matrix Stiffness Regulates Epithelial To Mesenchymal Transition In Rat Primary Type 1 Alveolar Epithelial Cells In Vitro." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5565.
Full textCremolini, Chiara, Rosa Berenato, Federica Morano, Roberto Moretto, Federica Perrone, Elena Tamborini, Daniele Rossini, et al. "Abstract LB-238: Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) inRASandBRAFwild-type (wt) metastatic colorectal cancer (mCRC)." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-lb-238.
Full textBoros, Ildiko´, Attila Aszo´di, and Ga´bor Le´gra´di. "Numerical Investigation of Thermal Stratification in the Primary Circuit of VVER-440 Type Reactors." In 14th International Conference on Nuclear Engineering. ASMEDC, 2006. http://dx.doi.org/10.1115/icone14-89529.
Full textNoh, Byeong Jae, Wha Soo Kim, Sun Hong Kwon, and Jang Young Chung. "Comparative Wet Drop Experiments of Mark III and KC-1 for Membrane Type LNG Carriers." In ASME 2009 28th International Conference on Ocean, Offshore and Arctic Engineering. ASMEDC, 2009. http://dx.doi.org/10.1115/omae2009-79289.
Full textPatel, Sagar S., Ramesh Natarajan, and Rebecca L. Heise. "Mechanotransduction of Primary Cilia in Lung Adenocarcinoma." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80435.
Full textReports on the topic "Primary hyperoxaluria type 1"
Wu, Xin. The efficacy and safety of anti-CD20 antibody treatments in relapsing multiple sclerosis: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0075.
Full textSplitter, Gary A., Menachem Banai, and Jerome S. Harms. Brucella second messenger coordinates stages of infection. United States Department of Agriculture, January 2011. http://dx.doi.org/10.32747/2011.7699864.bard.
Full textKungwankiattichai, Smith, Ben Ponvilawa, Claudie Roy, Pattaraporn Tunsing, Florian Kuchenbauer, and Weerapat Owattanapanich. Maintenance with Hypomethylating Agents after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2021. http://dx.doi.org/10.37766/inplasy2021.11.0078.
Full textBoyle, M., and Elizabeth Rico. Terrestrial vegetation monitoring at Fort Matanzas National Monument: 2019 data summary. National Park Service, May 2022. http://dx.doi.org/10.36967/nrds-2293409.
Full textBoyle, Maxwell, and Elizabeth Rico. Terrestrial vegetation monitoring at Fort Pulaski National Monument: 2019 data summary. National Park Service, December 2021. http://dx.doi.org/10.36967/nrds-2288716.
Full textSukenik, Assaf, Paul Roessler, and John Ohlrogge. Biochemical and Physiological Regulation of Lipid Synthesis in Unicellular Algae with Special Emphasis on W-3 Very Long Chain Lipids. United States Department of Agriculture, January 1995. http://dx.doi.org/10.32747/1995.7604932.bard.
Full textLundgren, Jonathan, Moshe Coll, and James Harwood. Biological control of cereal aphids in wheat: Implications of alternative foods and intraguild predation. United States Department of Agriculture, October 2014. http://dx.doi.org/10.32747/2014.7699858.bard.
Full textRine, Kristin, Roger Christopherson, and Jason Ransom. Harlequin duck (Histrionicus histrionicus) occurrence and habitat selection in North Cascades National Park Service Complex, Washington. National Park Service, April 2022. http://dx.doi.org/10.36967/nrr-2293127.
Full textSchiller, Brandon, Tara Hutchinson, and Kelly Cobeen. Cripple Wall Small-Component Test Program: Dry Specimens (PEER-CEA Project). Pacific Earthquake Engineering Research Center, University of California, Berkeley, CA, November 2020. http://dx.doi.org/10.55461/vsjs5869.
Full textUllman, Diane, James Moyer, Benjamin Raccah, Abed Gera, Meir Klein, and Jacob Cohen. Tospoviruses Infecting Bulb Crops: Evolution, Diversity, Vector Specificity and Control. United States Department of Agriculture, September 2002. http://dx.doi.org/10.32747/2002.7695847.bard.
Full text